A reappraisal of oophorectomy in carcinoma of the breast

U. Veronesi, N. Cascinelli, M. Greco, G. Di Fronzo, R. Oriana, M. Merson, D. Galluzzo, R. Bufalino, F. Belli, V. Sacchini

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Bilateral oophorectomy was used to treat 601 patients with disseminated breast carcinoma from 1974-1984. The total response rate was 31.2%. Complete regression occurred in 10.5% of patients and partial regression occurred in 20.8%, whereas 28.3% of patients showed no change and the disease progressed in 36.9% of patients. The patients who had a total regression had good survival rates (60.8% at 5 years and 47.3% at 7 years). No significant differences were found in the various age groups or with different types of dissemination. Patients with synchronous primary carcinoma and distant metastases had a high rate of regression as did patients with slow-growing carcinomas that metastasized many years after primary treatment. Estrogen receptor (ER) rates were good indicators of response only when determined on metastatic tissue at the time of oophorectomy. The value of ER determined on the primary tumor was of limited predictivity of response. A total of 220 patients received chemotherapy before oophorectomy. In this group the response rate was 22.3%, lower than that observed in patients who did not receive chemotherapy (36.6%). No important differences in total response rates were found among patients with amenorrhea and without amenorrhea although total regressions were more frequent in the latter patients than in the former patients.

Original languageEnglish
Pages (from-to)18-21
Number of pages4
JournalAnnals of Surgery
Volume205
Issue number1
Publication statusPublished - 1987

Fingerprint

Ovariectomy
Breast Neoplasms
Amenorrhea
Estrogen Receptors
Carcinoma
Drug Therapy
Survival Rate
Age Groups
Neoplasm Metastasis

ASJC Scopus subject areas

  • Surgery

Cite this

Veronesi, U., Cascinelli, N., Greco, M., Di Fronzo, G., Oriana, R., Merson, M., ... Sacchini, V. (1987). A reappraisal of oophorectomy in carcinoma of the breast. Annals of Surgery, 205(1), 18-21.

A reappraisal of oophorectomy in carcinoma of the breast. / Veronesi, U.; Cascinelli, N.; Greco, M.; Di Fronzo, G.; Oriana, R.; Merson, M.; Galluzzo, D.; Bufalino, R.; Belli, F.; Sacchini, V.

In: Annals of Surgery, Vol. 205, No. 1, 1987, p. 18-21.

Research output: Contribution to journalArticle

Veronesi, U, Cascinelli, N, Greco, M, Di Fronzo, G, Oriana, R, Merson, M, Galluzzo, D, Bufalino, R, Belli, F & Sacchini, V 1987, 'A reappraisal of oophorectomy in carcinoma of the breast', Annals of Surgery, vol. 205, no. 1, pp. 18-21.
Veronesi U, Cascinelli N, Greco M, Di Fronzo G, Oriana R, Merson M et al. A reappraisal of oophorectomy in carcinoma of the breast. Annals of Surgery. 1987;205(1):18-21.
Veronesi, U. ; Cascinelli, N. ; Greco, M. ; Di Fronzo, G. ; Oriana, R. ; Merson, M. ; Galluzzo, D. ; Bufalino, R. ; Belli, F. ; Sacchini, V. / A reappraisal of oophorectomy in carcinoma of the breast. In: Annals of Surgery. 1987 ; Vol. 205, No. 1. pp. 18-21.
@article{340b63ac8f104245a1dc5b10d6bacf54,
title = "A reappraisal of oophorectomy in carcinoma of the breast",
abstract = "Bilateral oophorectomy was used to treat 601 patients with disseminated breast carcinoma from 1974-1984. The total response rate was 31.2{\%}. Complete regression occurred in 10.5{\%} of patients and partial regression occurred in 20.8{\%}, whereas 28.3{\%} of patients showed no change and the disease progressed in 36.9{\%} of patients. The patients who had a total regression had good survival rates (60.8{\%} at 5 years and 47.3{\%} at 7 years). No significant differences were found in the various age groups or with different types of dissemination. Patients with synchronous primary carcinoma and distant metastases had a high rate of regression as did patients with slow-growing carcinomas that metastasized many years after primary treatment. Estrogen receptor (ER) rates were good indicators of response only when determined on metastatic tissue at the time of oophorectomy. The value of ER determined on the primary tumor was of limited predictivity of response. A total of 220 patients received chemotherapy before oophorectomy. In this group the response rate was 22.3{\%}, lower than that observed in patients who did not receive chemotherapy (36.6{\%}). No important differences in total response rates were found among patients with amenorrhea and without amenorrhea although total regressions were more frequent in the latter patients than in the former patients.",
author = "U. Veronesi and N. Cascinelli and M. Greco and {Di Fronzo}, G. and R. Oriana and M. Merson and D. Galluzzo and R. Bufalino and F. Belli and V. Sacchini",
year = "1987",
language = "English",
volume = "205",
pages = "18--21",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - A reappraisal of oophorectomy in carcinoma of the breast

AU - Veronesi, U.

AU - Cascinelli, N.

AU - Greco, M.

AU - Di Fronzo, G.

AU - Oriana, R.

AU - Merson, M.

AU - Galluzzo, D.

AU - Bufalino, R.

AU - Belli, F.

AU - Sacchini, V.

PY - 1987

Y1 - 1987

N2 - Bilateral oophorectomy was used to treat 601 patients with disseminated breast carcinoma from 1974-1984. The total response rate was 31.2%. Complete regression occurred in 10.5% of patients and partial regression occurred in 20.8%, whereas 28.3% of patients showed no change and the disease progressed in 36.9% of patients. The patients who had a total regression had good survival rates (60.8% at 5 years and 47.3% at 7 years). No significant differences were found in the various age groups or with different types of dissemination. Patients with synchronous primary carcinoma and distant metastases had a high rate of regression as did patients with slow-growing carcinomas that metastasized many years after primary treatment. Estrogen receptor (ER) rates were good indicators of response only when determined on metastatic tissue at the time of oophorectomy. The value of ER determined on the primary tumor was of limited predictivity of response. A total of 220 patients received chemotherapy before oophorectomy. In this group the response rate was 22.3%, lower than that observed in patients who did not receive chemotherapy (36.6%). No important differences in total response rates were found among patients with amenorrhea and without amenorrhea although total regressions were more frequent in the latter patients than in the former patients.

AB - Bilateral oophorectomy was used to treat 601 patients with disseminated breast carcinoma from 1974-1984. The total response rate was 31.2%. Complete regression occurred in 10.5% of patients and partial regression occurred in 20.8%, whereas 28.3% of patients showed no change and the disease progressed in 36.9% of patients. The patients who had a total regression had good survival rates (60.8% at 5 years and 47.3% at 7 years). No significant differences were found in the various age groups or with different types of dissemination. Patients with synchronous primary carcinoma and distant metastases had a high rate of regression as did patients with slow-growing carcinomas that metastasized many years after primary treatment. Estrogen receptor (ER) rates were good indicators of response only when determined on metastatic tissue at the time of oophorectomy. The value of ER determined on the primary tumor was of limited predictivity of response. A total of 220 patients received chemotherapy before oophorectomy. In this group the response rate was 22.3%, lower than that observed in patients who did not receive chemotherapy (36.6%). No important differences in total response rates were found among patients with amenorrhea and without amenorrhea although total regressions were more frequent in the latter patients than in the former patients.

UR - http://www.scopus.com/inward/record.url?scp=0023119622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023119622&partnerID=8YFLogxK

M3 - Article

VL - 205

SP - 18

EP - 21

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 1

ER -